Literature DB >> 7449465

Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us?

B A Keogh, R G Crystal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7449465     DOI： 10.1378/chest.78.6.856

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  17 in total

Review 1.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  Interstitial lung disease: aggressive clinical management versus diagnostic and therapeutic nihilism.

Authors:  R G Crystal
Journal:  West J Med       Date:  1982-04

4.  Direct measurement of IGF-I and IGFBP-3 in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis.

Authors:  L Pala; S Giannini; E Rosi; B Cresci; G Scano; S Mohan; R Duranti; C M Rotella
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

5.  Suppression of the alveolitis in pulmonary sarcoidosis by oral corticosteroids.

Authors:  G A Rossi; G B Di Negro; E Balzano; E Cerri; O Sacco; B Balbi; A Venturini; R Ramoino; C Ravazzoni
Journal:  Lung       Date:  1985       Impact factor: 2.584

6.  Functional similarities of asbestosis and cryptogenic fibrosing alveolitis.

Authors:  J Markos; A W Musk; K E Finucane
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

7.  Ultrasound Strain Measurements for Evaluating Local Pulmonary Ventilation.

Authors:  Jonathan M Rubin; Jeffrey C Horowitz; Thomas H Sisson; Kang Kim; Luis A Ortiz; James D Hamilton
Journal:  Ultrasound Med Biol       Date:  2016-08-10       Impact factor: 2.998

8.  Correlation between pulmonary fibrosis and the lung pressure-volume curve.

Authors:  R H Sansores; A Ramirez-Venegas; R Pérez-Padilla; M Montaño; C Ramos; C Becerril; M Gaxiola; P Paré; M Selman
Journal:  Lung       Date:  1996       Impact factor: 2.584

9.  Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests.

Authors:  R Bégin; M Rola-Pleszczynski; S Massé; D Nadeau; G Drapeau
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

10.  Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease.

Authors:  S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.